Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: Part I
- 31 December 2004
- journal article
- review article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 22 (6) , 466-471
- https://doi.org/10.1016/j.urolonc.2004.10.001
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Randomized Trials of Vitamin E in the Treatment and Prevention of Cardiovascular DiseaseArchives of internal medicine (1960), 2004
- Incidence of Cancer and Mortality Following α-Tocopherol and β-Carotene SupplementationJAMA, 2003
- The Influence of Finasteride on the Development of Prostate CancerNew England Journal of Medicine, 2003
- Primary Prevention of Cardiovascular DiseaseCirculation, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Relationship of Baseline Serum Cholesterol Levels in 3 Large Cohorts of Younger Men to Long-term Coronary, Cardiovascular, and All-Cause Mortality and to LongevityJAMA, 2000
- Early Detection of High Cholesterol Levels in Young AdultsJAMA, 2000
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Prostate Cancer and Supplementation With α-Tocopherol and β-Carotene: Incidence and Mortality in a Controlled TrialJNCI Journal of the National Cancer Institute, 1998
- Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study GroupJAMA, 1996